Health·2,850 stories
Regulators in the U.S. and Brazil are moving on high‑profile drugs: the FDA has delayed its decision on AstraZeneca’s experimental breast‑cancer therapy pending more data, while Brazil’s health agency
Google Health unveiled a roadmap that lists bug fixes and new improvements, aiming to bring health data together under one platform. The rollout, highlighted on Google’s blog and covered by 9to5Google
STAT’s AI Prognosis newsletter spotlights a surge of anti‑AI sentiment among graduating seniors, who feel forced to use the technology despite their dislike. The author cites a Defector piece and cred
Amid a news cycle dominated by US‑Iran tensions, the NFL’s global schedule rollout, and Meta’s AI‑driven Threads, a UC San Diego team unveiled ION224, a DGAT2‑blocking drug that dramatically improves
University of Connecticut researchers published in PNAS that the anti‑aging cocktail dasatinib plus quercetin triggers severe myelin loss in mouse brains, with younger mice showing the greatest damage
Aalto University researchers developed a near-infrared laser treatment that gently heats retinal tissue to activate natural repair systems, showing promise in animal studies as an early intervention f
At the Vitalist Bay longevity conference in Berkeley, Rythm Health’s Robby Wade showcased at‑home blood‑draw tech while organizers like Adam Gries framed the event as a rally against inevitable aging.
Stanford’s health system is pioneering a patient‑first approach to AI, convening a panel of caregivers like Eric Gries to vet new tools before they go live. The initiative, part of a broader push to e
A BMJ Nutrition Prevention & Health review of 17 studies found guava juice can raise hemoglobin levels by an average of 1.71 g/dl in women and teenage girls, with even stronger results when paired wit
Vitamin B12 is essential for blood, nerves and DNA repair, yet both deficiency and excess may raise cancer risk. A Vietnamese case‑control study found a U‑shaped link between intake and cancer, and lo
Japanese researchers at Shibaura Institute of Technology have engineered a new class of vitamin K analogues that are roughly three times more potent at coaxing neural stem cells into neurons. Publishe
A new global analysis of facial attractiveness shows women’s faces are consistently rated as more attractive than men’s across cultures and sexual orientations, but the gap shrinks with age and disapp
A first-of-its-kind Lancet Planetary Health study quantitatively links climate change to a 10% global rise in salmonella antibiotic resistance genes from 1940 to 2023, with the Middle East, North Afri
Three teenage patients died by suicide while under the care of the Tees, Esk and Wear Valleys NHS Foundation Trust, prompting an independent report that called the unit chaotic and unsafe. Families an
SpaceX's IPO filing and its third Starship test flight expose a tension at the heart of Elon Musk's space business: Starlink's growth is slowing, Starship's reusability remains unproven, and the rocke
Republicans are pressing an immigration funding bill through Congress, but internal budget disputes are stalling progress. A $1.8 billion settlement fund for Trump’s allies halted a Senate vote on the
Space‑weather events can induce currents that corrupt railway signalling, turning red lights green or vice‑versa. A 1982 Swedish storm and recent Russian data show real‑world glitches, and experts war
As Russia’s relentless missile attacks continue to claim Ukrainian lives and Europe’s electrification stalls, a quieter danger looms over rail networks: space weather that can flip signals and spark a
Texas A&M scientists have unveiled a nasal spray that, after just two doses, reduces brain inflammation and restores memory, offering a non‑invasive route to reverse age‑related cognitive decline. The
Eli Lilly’s high‑dose gene‑editing therapy slashed LDL cholesterol by 62% in a Phase 1 trial without serious safety issues. The company is now moving to Phase 2 and is expanding its infectious‑disease
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.